Centauri Therapeutics Limited – Trademark Portfolio

Entity Type: 24

Centauri Therapeutics Limited holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 1 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include AVVINITY. The owner is based in London.

Thavies Inn House 1st Floor

3-4 Holborn Circus

London EC1N2HA , GB

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AVVINITY
AVVINITY
Registered 2016

Trademark Classifications

Centauri Therapeutics Limited's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (1 filing)

Scientific and technological services; industrial analysis and research services

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Centauri Therapeutics Limited have?

Centauri Therapeutics Limited has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 cancelled.

What trademark classes does Centauri Therapeutics Limited file in?

Centauri Therapeutics Limited files trademarks across 2 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Centauri Therapeutics Limited's most well-known trademarks?

Centauri Therapeutics Limited's registered trademark portfolio includes well-known marks such as AVVINITY. These are among 1 currently registered trademark in the portfolio.

What is Centauri Therapeutics Limited's trademark registration success rate?

Centauri Therapeutics Limited has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.